Full Papers
Contribution of dot-blot assay to the diagnosis and management of myositis: a three-year practice at a university hospital centre
C. Martel1, G. Vignaud2, E. Liozon3, L. Magy4, G. Gallouedec5, K. Ly6, H. Bezanahary7, A. Cypierre8, F.-X. Lapébie9, S. Palat10, G. Gondran11, M.-O. Jauberteau12, A.-L. Fauchais13
- Department of Internal Medicine, and Department of Immunology, Limoges University Hospital, France.
- Department of Internal Medicine, Limoges University Hospital, France.
- Department of Internal Medicine, Limoges University Hospital, France.
- Department of Neurology, Centre de Référence “Neuropathies Périphériques Rares”, Limoges University Hospital, France.
- Department of Neurology, Centre de Référence “Neuropathies Périphériques Rares”, Limoges University Hospital, France.
- Department of Internal Medicine, Limoges University Hospital, France.
- Department of Internal Medicine, Limoges University Hospital, France.
- Department of Internal Medicine, Limoges University Hospital, France.
- Department of Internal Medicine, Limoges University Hospital, France.
- Department of Internal Medicine, Limoges University Hospital, France.
- Department of Internal Medicine, Limoges University Hospital, France.
- Department of Immunology, Limoges University Hospital, France.
- Department of Internal Medicine, Limoges University Hospital, France. anne-laure.fauchais@unilim.fr
CER9080
2016 Vol.34, N°5
PI 0918, PF 0924
Full Papers
Free to view
(click on article PDF icon to read the article)
PMID: 27494325 [PubMed]
Received: 29/10/2015
Accepted : 16/05/2016
In Press: 02/08/2016
Published: 16/09/2016
Abstract
OBJECTIVES:
Idiopathic inflammatory myopathies (IIM) are heterogeneous autoimmune diseases with wide clinical spectrum that may lead to delayed diagnosis. The aim of this study was to examine the impact of IIM-specific dot-blot assay on diagnostic process of patients presenting with muscular or systemic symptoms evocating of IIM.
METHODS:
We collected all the prescriptions of an IIM specific dot-blot assay (8 autoantigens including Jo-1, PL-7, PL-12, SRP, Mi-2, Ku, PM/Scl and Scl-70) over a 38-month period.
RESULTS:
316 myositis dot-blot assays (MSD) were performed in 274 patients (156 women, mean age 53±10.6 years) referring for muscular and/or systemic symptoms suggesting IIM. The timing of dot prescription through the diagnostic process was highly variable: without (35%), concomitantly (16%) or after electromyographic studies (35%). Fifty-nine patients (22%) had IIM according to Bohan and Peter’s criteria. Among them, 29 (49%) had positive dot (8 Jo-1, 6 PM-Scl, 5 PL-12, 5 SRP, 2 Mi-2, 2 PL-7 and 1 Ku). Various other diagnoses were performed including 35 autoimmune disease or granulomatosis (12%), 19 inflammatory rheumatic disease (7%), 16 non inflammatory muscular disorders (6%), 10 drug-induced myalgia (4%), 11 infectious myositis (4%). Except 11 borderline SRP results and one transient PM-Scl, MSD was positive only in one case of IIM. Dot allowed clinicians to correct diagnosis in 4 cases and improved the diagnosis of IIM subtypes in 4 cases.
CONCLUSIONS:
This study reflects the interest of myositis dot in the rapid diagnosis process of patients with non-specific muscular symptoms leading to various diagnoses including IIM.